AUSTIN, Texas, Nov. 1, 2017 /Weed Wire/ — Compassionate Cultivation is ready to make history in the Lone Star State by planting one of Texas’ first legal cannabis crops.
The medical cannabis company—one of two businesses licensed to grow cannabis that is high in non-psychoactive cannabidiol (CBD) and low in psychoactive tetrahydrocannabinol (THC) in Texas—received its state license today and will immediately start cultivating its first crop inside its vertically integrated Austin facility.
“Our business philosophy is built around a world-class team and responsible leadership that exceeds the state’s expectations,” says Compassionate Cultivation CEO Morris Denton. “And most importantly we’re excited to deliver on the promise of low-THC cannabis to the Texas medical community—and to the many patients and families hoping that CBD-rich cannabis oil can help stop the cycle of suffering.”
The Texas Compassionate Use Act, signed by Gov. Greg Abbott in 2015, legalized the cultivation of CBD-rich cannabis—and the sale of an oil derived from that cannabis—to patients suffering from intractable epilepsy. Compassionate Cultivation won one of the state’s licenses to cultivate plants and extract and retail the cannabis oil earlier this summer.
Pending final approval from the Texas Department of Public Safety, Compassionate Cultivation plans to start selling its cannabis oil as early as January 2018—after the first batch of plants are harvested and cured, after the oil is extracted from the plant matter, and after the oil has been tested for purity and safety.
Compassionate Cultivation has enlisted industry-leading cannabis management consultancy MJardin—which provides turn-key cultivation and processing services—to operate its grow, thus completing a team that is as esteemed as it is passionate.
Another essential team member is Compassionate Cultivation chief medical officer Dr. Karen Keough, a Board Certified Child Neurologist who specializes in treating intractable epilepsy at Child Neurology Consultants of Austin.
“The medical community has struggled to understand CBD, and even though we still have a long way to go, we’ve learned so much that has legitimized this cannabis-based medicine over the last three-to-five years, but especially in the last six months—and this is only the beginning,” says Dr. Keough, who also chairs the Child Neurology Society’s Educational Special Interest Group and serves on the Neurology Child Examination Committee for the American Board of Psychiatry and Neurology. “My partners and I are looking forward to responsibly integrating CBD into our treatment regimens, and I very much look forward to helping other physicians better understand CBD and how it may help some of their patients.
“I know many of my patients are incredibly excited about this. For them, it’s a new and promising opportunity to manage this devastating neurological disorder when more traditional options just aren’t working.”
As Dr. Keough wrote in a recent Texas Tribune column, “I myself have gone from cautioning patients not to expect too much from CBD to saying, ‘Let’s see what happens,’ to realizing that, for many patients, CBD not only meets their needs but exceeds all of our expectations. And now I look forward to 2018, when we’ll finally be able to deliver this important plant-based medicine to the Texans who need it most.”
Compassionate Cultivation’s operations partner MJardin—which currently manages over 30 licensed cultivation facilities in 13 U.S. states and two countries—has an exceptional track record in operating cannabis facilities. MJardin facilities have produced well over 150,000 pounds of consistently high-quality finished product since its inception in 2014, making it the largest cultivator of legal cannabis in the world.
“MJardin and the Compassionate Cultivation team have worked seamlessly throughout the process thus far,” says MJardin Chairman and CEO Rishi Gautam. “And the fact that we are about to achieve an unprecedented five-month stand up from provisional license to final license is a testament to the level of expertise this team will bring to the medical cannabis community of Texas.”
MJardin will partner with Compassionate Cultivation to implement rigorous quality control measures in compliance with Texas legislative requirements to ensure consistency of product and freedom from contaminants.
About Compassionate Cultivation
Compassionate Cultivation is a home-grown medical cannabis company serving patients throughout America’s second-most populous state. As the only Texas-licensed cannabis business from the Lone Star State, Compassionate Cultivation is dedicated to representing the integrity of this great land and helping patients and families in need—and the physicians recommending their cannabis-based medicine. For more information, please visit compassionatecultivationtx.com.
MJardin Management is a highly specialized professional operating company that develops partnerships with licensed operators. MJardin provides their partners turnkey cannabis cultivation and processing solutions including licensure support, facility design, systems implementation, facility ramp-up and the day-to-day operational management required in a large-scale, professionally managed cannabis facility. For more information, please visit MJardin.com.
For more information on Compassionate Cultivation:
Nora Olabi, Grasslands: email@example.com, 832-419-2515
For more information on MJardin:
Kara Devine, MJardin: firstname.lastname@example.org, 720-613-4019